A Humanized Mouse Model of Tuberculosis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Calderon, Veronica E ^a   Valbuena, Gustavo ^a   Goez, Yenny ^a   Judy, Barbara M ^a   Huante, Matthew B ^a   Sutjita, Putri ^a   Johnston, R Katie ^a   Estes, D Mark ^b   Hunter, Robert L ^c   Actor, Jeffrey K ^c   Cirillo, Jeffrey D ^d   Endsley, Janice J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULYSIN; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CD3+ T LYMPHOCYTE; CD34 SELECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; CRYSTALLIZATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TUBERCULOSIS; ANIMAL; BONE MARROW TRANSPLANTATION; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; LIVER; LUNG; NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SCID MOUSE; T LYMPHOCYTE; THYMUS;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; LIVER; LUNG; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES; THYMUS GLAND; TUBERCULOSIS;

EID: 84877855586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063331     Document Type: Article

References (61)

1. WHO (2012) Global tuberculosis report 2012.
2. Raviglione M, Marais B, Floyd K, Lonnroth K, Getahun H, et al. (2012) Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379: 1902-1913.
3. Babu GR, Laxminarayan R, (2012) The unsurprising story of MDR-TB resistance in India. Tuberculosis (Edinb) 92: 301-306.
4. Ly LH, McMurray DN, (2009) The Yin-Yang of TNF-α in the guinea pig model of tuberculosis. Indian J Exp Biol 47: 432-439.
5. Kaushal D, Mehra S, Didier PJ, Lackner AA, (2012) The non-human primate model of tuberculosis. J Med Primatol 41: 191-201.
6. Helke KL, Mankowski JL, Manabe YC, (2006) Animal models of cavitation in pulmonary tuberculosis. Tuberculosis (Edinb) 86: 337-348.
7. Flynn JL, Capuano SV, Croix D, Pawar S, Myers A, et al. (2003) Non-human primates: a model for tuberculosis research. Tuberculosis (Edinb) 83: 116-118.
8. Flynn JL, (2006) Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 8: 1179-1188.
9. Basaraba RJ, (2008) Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb) 88Suppl 1: S35-47.
10. Harper J, Skerry C, Davis SL, Tasneen R, Weir M, et al. (2012) Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J Infect Dis 205: 595-602.
11. Hunter RL, Jagannath C, Actor JK, (2007) Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb) 87: 267-278.
12. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76: 2333-2340.
13. Mehra S, Golden NA, Dutta NK, Midkiff CC, Alvarez X, et al. (2011) Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus. J Med Primatol 40: 233-243.
14. Mattila JT, Diedrich CR, Lin PL, Phuah J, Flynn JL, (2011) Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation. J Immunol 186: 3527-3537.
15. Diedrich CR, Mattila JT, Klein E, Janssen C, Phuah J, et al. (2010) Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS One 5: e9611.
16. Brenchley JM, Paiardini M, (2011) Immunodeficiency lentiviral infections in natural and non-natural hosts. Blood 118: 847-854.
17. Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, et al. (2007) Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 204: 705-714.
18. Marsden MD, Kovochich M, Suree N, Shimizu S, Mehta R, et al. (2012) HIV latency in the humanized BLT mouse. J Virol 86: 339-347.
19. Denton PW, Olesen R, Choudhary SK, Archin NM, Wahl A, et al. (2012) Generation of HIV latency in humanized BLT mice. J Virol 86: 630-634.
20. Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, et al. (2009) Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 83: 7305-7321.
21. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, et al. (2010) Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A 107: 15589-15594.
22. Bente DA, Melkus MW, Garcia JV, Rico-Hesse R, (2005) Dengue fever in humanized NOD/SCID mice. J Virol 79: 13797-13799.
23. Arnold L, Tyagi RK, Meija P, Swetman C, Gleeson J, et al. (2011) Further improvements of the P. falciparum humanized mouse model. PLoS One 6: e18045.
24. Ito R, Takahashi T, Katano I, Ito M, (2012) Current advances in humanized mouse models. Cell Mol Immunol 9: 208-214.
25. Denton PW, Garcia JV, (2011) Humanized mouse models of HIV infection. AIDS Rev 13: 135-148.
26. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, et al. (2006) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12: 1316-1322.
27. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, et al. (2010) Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r γ(null) humanized mice. Proc Natl Acad Sci U S A 107: 13022-13027.
28. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, et al. (2009) The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γc(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 21: 843-858.
29. Andre MC, Erbacher A, Gille C, Schmauke V, Goecke B, et al. (2010) Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R γ (null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells. J Immunol 185: 2710-2720.
30. Hogg AE, Bowick GC, Herzog NK, Cloyd MW, Endsley JJ, (2009) Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1. J Leukoc Biol 86: 1191-1203.
31. Kong Y, Akin AR, Francis KP, Zhang N, Troy TL, et al. (2011) Whole-body imaging of infection using fluorescence. Curr Protoc Microbiol Chapter 2: Unit 2C 3.
32. Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, et al. (2010) Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One 5: e8829.
33. Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, et al. (2008) Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 5: e16.
34. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, et al. (2009) Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rγnull mice. PLoS One 4: e7251.
35. Moreno A, Ferrer E, Arahuetes S, Eguiluz C, Van Rooijen N, et al. (2006) The course of infections and pathology in immunomodulated NOD/LtSz-SCID mice inoculated with Plasmodium falciparum laboratory lines and clinical isolates. Int J Parasitol 36: 361-369.
36. Gille C, Orlikowsky TW, Spring B, Hartwig UF, Wilhelm A, et al. (2012) Monocytes derived from humanized neonatal NOD/SCID/IL2Rγ(null) mice are phenotypically immature and exhibit functional impairments. Hum Immunol 73: 346-354.
37. Tanaka S, Saito Y, Kunisawa J, Kurashima Y, Wake T, et al. (2012) Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice. J Immunol 188: 6145-6155.
38. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, et al. (1996) A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-1949.
39. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 178: 2243-2247.
40. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, et al. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282: 121-125.
41. Ochoa MT, Stenger S, Sieling PA, Thoma-Uszynski S, Sabet S, et al. (2001) T-cell release of granulysin contributes to host defense in leprosy. Nat Med 7: 174-179.
42. Endsley JJ, Hogg A, Shell LJ, McAulay M, Coffey T, et al. (2007) Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity. Vaccine 25: 8384-8394.
43. Endsley JJ, Endsley MA, Estes DM, (2006) Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. J Leukoc Biol 79: 71-79.
44. Dieli S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, et al. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282: 121-125.
45. Endsley JJ, Furrer JL, Endsley MA, McIntosh MA, Maue AC, et al. (2004) Characterization of bovine homologues of granulysin and NK-lysin. J Immunol 173: 2607-2614.
46. Andersson J, Samarina A, Fink J, Rahman S, Grundstrom S, (2007) Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect Immun 75: 5210-5222.
47. Zheng CF, Ma LL, Jones GJ, Gill MJ, Krensky AM, et al. (2007) Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients. Blood 109: 2049-2057.
48. Hogg A, Huante M, Ongaya A, Williams J, Ferguson M, et al. (2011) Activation of NK cell granulysin by mycobacteria and IL-15 is differentially affected by HIV. Tuberculosis (Edinb) 91Suppl 1: S75-81.
49. Zelmer A, Carroll P, Andreu N, Hagens K, Mahlo J, et al. (2012) A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. J Antimicrob Chemother 67: 1948-1960.
50. Hoff DR, Ryan GJ, Driver ER, Ssemakulu CC, De Groote MA, et al. (2011) Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment. PLoS One 6: e17550.
51. Kramnik I, Dietrich WF, Demant P, Bloom BR, (2000) Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 97: 8560-8565.
52. Driver ER, Ryan GJ, Hoff DR, Irwin SM, Basaraba RJ, et al. (2012) Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother 56: 3181-3195.
53. Hunter RL, Olsen M, Jagannath C, Actor JK, (2006) Trehalose 6,6′-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol 168: 1249-1261.
54. Guidry TV, Hunter RL Jr, Actor JK, (2006) CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6′-dimycolate in mice. Microbiology 152: 3765-3775.
55. Homolka S, Niemann S, Russell DG, Rohde KH, (2010) Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog 6: e1000988.
56. Collins J, Blankenbaker D, Stern EJ, (1998) CT patterns of bronchiolar disease: what is "tree-in-bud"? AJR Am J Roentgenol 171: 365-370.
57. Hunter RL, (2011) Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinb) 91: 497-509.
58. Huynh KK, Joshi SA, Brown EJ, (2011) A delicate dance: host response to mycobacteria. Curr Opin Immunol 23: 464-472.
59. McCune RMTR, McDermott W, (1957) The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med 104: 763-802.
60. Larsen MH, Biermann K, Jacobs WR Jr (2007) Laboratory maintenance of Mycobacterium tuberculosis. Curr Protoc Microbiol Chapter 10: Unit 10A 11.
61. Kong Y, Yao H, Ren H, Subbian S, Cirillo SL, et al. (2010) Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A 107: 12239-12244.